Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents

被引：0
|
作者：
Jean-Marc Barret
Anna Kruczynski
Chantal Etiévant
Bridget T. Hill
机构：
[1] Division de Cancérologie,
[2] Centre de Recherche Pierre Fabre,undefined
[3] 17 avenue Jean Moulin,undefined
[4] 81100 Castres,undefined
[5] France,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2002年 / 49卷
关键词：
F 11782 Combination index Synergy Cultured cells In vivo;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：479 / 486
页数：7
相关论文
共 50 条
  • [21] Novel angular benzophenazines: Dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents
    Vicker, N
    Burgess, L
    Chuckowree, IS
    Dodd, R
    Folkes, AJ
    Hardick, DJ
    Hancox, TC
    Miller, W
    Milton, J
    Sohal, S
    Wang, SM
    Wren, SP
    Charlton, PA
    Dangerfield, W
    Liddle, C
    Mistry, P
    Stewart, AJ
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 721 - 739
  • [22] THE EFFECTS OF ICRF-154 IN COMBINATION WITH OTHER ANTICANCER AGENTS INVITRO
    KANO, Y
    NARITA, T
    SUZUKI, K
    AKUTSU, M
    SUDA, K
    SAKAMOTO, S
    MIURA, Y
    BRITISH JOURNAL OF CANCER, 1992, 66 (02) : 281 - 286
  • [23] EFFECTS OF CPT-11 IN COMBINATION WITH OTHER ANTICANCER AGENTS IN CULTURE
    KANO, Y
    SUZUKI, K
    AKUTSU, M
    SUDA, K
    INOUE, Y
    YOSHIDA, M
    SAKAMOTO, S
    MIURA, Y
    INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (04) : 604 - 610
  • [24] Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer
    Ali, Doaa Mohamed Elroby
    Aziz, Hossameldin A.
    Brase, Stefan
    Al Bahir, Areej
    Alkhammash, Abdullah
    Abuo-Rahma, Gamal El-Din A.
    Elshamsy, Ali M.
    Hashem, Hamada
    Abdelmagid, Walid M.
    MOLECULES, 2024, 29 (22):
  • [25] Synergistic effects of natural products in combination with anticancer agents in prostate cancer: A scoping review
    Cheon, Chunhoo
    Ko, Seong-Gyu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] EFFECTS OF MITOXANTRONE IN COMBINATION WITH OTHER ANTICANCER AGENTS ON A HUMAN LEUKEMIA-CELL LINE
    KANO, Y
    SUZUKI, K
    AKUTSU, M
    SUDA, K
    LEUKEMIA, 1992, 6 (05) : 440 - 445
  • [27] EFFECTS OF CARBOPLATIN IN COMBINATION WITH OTHER ANTICANCER AGENTS ON HUMAN LEUKEMIA-CELL LINES
    KANO, Y
    AKUTSU, M
    SUZUKI, K
    YOSHIDA, M
    LEUKEMIA RESEARCH, 1993, 17 (02) : 113 - 119
  • [28] Phase I and II trials of novel anticancer agents: Endpoints, efficacy and existentialism
    Eisenhauer, EA
    ANNALS OF ONCOLOGY, 1998, 9 : 9 - 9
  • [29] In vitro synergistic effects of anticancer drugs in combination with vinflunine, a novel fluorinated Vinca alkaloid
    Barret, JM
    Etievant, C
    Limouzy, A
    Cabrol, N
    Vincenti, M
    Hill, BT
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [30] Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells
    Pan, Xiaobei
    Hartley, Janet M.
    Hartley, John A.
    White, Kenneth N.
    Wang, Zhengtao
    Bligh, S. W. Annie
    PHYTOMEDICINE, 2012, 19 (07) : 618 - 624
12345